Let’s Move From Categorizing MS by Clinical Phenotype to Underlying Disease Mechanisms
Could a new model for characterizing multiple sclerosis lead to better patient outcomes? An expert makes the case for focusing on underlying biological processes of the disease. The way forward for multiple sclerosis care may be a personalized medicine approach built on understanding immunopathologic underpinnings of the disease in individuals.